Not Just a Sum? Identifying Different Types of Interplay between Constituents in Combined Interventions

PLoS One. 2015 May 12;10(5):e0125334. doi: 10.1371/journal.pone.0125334. eCollection 2015.

Abstract

Motivation: Experiments in which the effect of combined manipulations is compared with the effects of their pure constituents have received a great deal of attention. Examples include the study of combination therapies and the comparison of double and single knockout model organisms. Often the effect of the combined manipulation is not a mere addition of the effects of its constituents, with quite different forms of interplay between the constituents being possible. Yet, a well-formalized taxonomy of possible forms of interplay is lacking, let alone a statistical methodology to test for their presence in empirical data.

Results: Starting from a taxonomy of a broad range of forms of interplay between constituents of a combined manipulation, we propose a sound statistical hypothesis testing framework to test for the presence of each particular form of interplay. We illustrate the framework with analyses of public gene expression data on the combined treatment of dendritic cells with curdlan and GM-CSF and show that these lead to valuable insights into the mode of action of the constituent treatments and their combination.

Availability and implementation: R code implementing the statistical testing procedure for microarray gene expression data is available as supplementary material. The data are available from the Gene Expression Omnibus with accession number GSE32986.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Computer Simulation
  • Databases, Genetic
  • Dendritic Cells / drug effects*
  • Dendritic Cells / metabolism
  • Drug Therapy, Combination
  • Gene Expression Profiling
  • Gene Expression Regulation / drug effects*
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • Mice
  • Models, Statistical
  • Oligonucleotide Array Sequence Analysis
  • Pattern Recognition, Automated / methods*
  • beta-Glucans / pharmacology*

Substances

  • beta-Glucans
  • curdlan
  • Granulocyte-Macrophage Colony-Stimulating Factor

Grants and funding

The research reported in this paper was supported by GlaxoSmithKline Biologicals S.A., by the Fund for Scientific Research Flanders (G.0546.09N), and by the Belgian Federal Science Policy Office (IUAP P7/06). LT is a Post-doctoral Fellow of the Research Foundation – Flanders (FWO). The funder provided support in the form of salaries for authors [RvdB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.